In-vivo observations on angiogenesis: Dose-dependent effects of the prolyl-4-hydroxylase inhibitor, di-methyl oxalyl-glycine, on arterial development in embryonic zebrafish

In-vivo observations on angiogenesis: Dose-dependent effects of the prolyl-4-hydroxylase inhibitor, di-methyl oxalyl-glycine, on arterial development in embryonic zebrafish

Bibliographic Details
Main Authors:	Kelly, D, Mecinovic, J, Schofield, C, Gunn, J, Gershlick, A, Chico, T
Format:	Conference item
Published:	2008

Similar Items

In-vivo observations on angiogenesis in embryonic zebrafish: dose-dependent effects of the prolyl-4-hydroxylase inhibitor, Di-methyl oxalyl-glycine, on arterial development
by: Kelly, D, et al.
Published: (2008)

UPREGULATION OF HYPDXIA-INDUCIBLE FACTOR 1 alpha BY DI-METHYL OXALYL GLYCINE PROMOTES ANGIOGENESIS WITHIN ISCHAEMIC MYOCARDIUM IN A PORCINE CORONARY OCCLUSION MODEL
by: Kelly, D, et al.
Published: (2010)

74 Pro-Angiogenic Effects of the Prolyl-hydroxylase Inhibitor FG-2216/BIQ: Therapeutic Angiogenesis for the Treatment of Chronic Total Occlusions.
by: Barnett, G, et al.
Published: (2014)

Mass spectrometric studies on an oxygen sensing prolyl hydroxylase
by: Mecinovic, J, et al.
Published: (2007)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
by: Mecinović, J, et al.
Published: (2009)

BIOL 56-ESI-MS studies on prolyl hydroxylase domain 2
by: Mecinovic, J, et al.
Published: (2008)

Use of mass spectrometry to probe the nucleophilicity of cysteinyl residues of prolyl hydroxylase domain 2.
by: Mecinović, J, et al.
Published: (2009)

Evidence for a potential new method of therapeutic angiogenesis: Increased endothelial cell mobility and tubule formation in cell culture after stabilisation of hypoxia-inducible factor
by: Kelly, D, et al.
Published: (2008)

Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
by: Chowdhury, R, et al.
Published: (2009)

Inhibition of a viral prolyl hydroxylase
by: Langley, G, et al.
Published: (2019)

ESI-MS studies on prolyl hydroxylase domain 2 reveal a new metal binding site.
by: Mecinović, J, et al.
Published: (2008)

The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.
by: Barnett, G, et al.
Published: (2013)

Prolyl hydroxylases and therapeutics.
by: Smith, T, et al.
Published: (2010)

Small-molecules that covalently react with a human prolyl hydroxylase – towards activity modulation and substrate capture
by: Bush, J, et al.
Published: (2018)

Increased endothelial cell mobility following stabilization of hypoxia-inducible factor-steps towards therapeutic angiogenesis
by: Kelly, D, et al.
Published: (2008)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
by: Lippl, K, et al.
Published: (2015)

Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1)
by: Chowdhury, R, et al.
Published: (2011)

Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1).
by: Chowdhury, R, et al.
Published: (2011)

Regulation of HIF: prolyl hydroxylases.
by: Stolze, I, et al.
Published: (2006)

Substrate selectivity of prolyl hydroxylases
by: McDonough, M
Published: (2018)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
by: McNeill, L, et al.
Published: (2002)

2-oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2
by: Abboud, M, et al.
Published: (2018)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
by: Mole, D, et al.
Published: (2003)

Differential prolyl hydroxylation by six Physcomitrella prolyl-4 hydroxylases
by: Christine Rempfer, et al.
Published: (2024-12-01)

Structural basis of prolyl hydroxylase domain inhibition by Molidustat
by: Figg, WD, et al.
Published: (2021)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
by: Schlemminger, I, et al.
Published: (2003)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
by: Hewitson, K, et al.
Published: (2007)

Structural, functional and evolutionary studies on prolyl-hydroxylases
by: Scotti, J
Published: (2014)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
by: Yeoh, K, et al.
Published: (2013)

Structural and mechanistic studies on prolyl hydroxylases
by: Chowdhury, R
Published: (2008)

Pro-angiogenic effects of proly-hydroxylase inhibitor FG-2216 and potential for use in a novel strategy of therapeutic angiogenesis for difficult cases of coronary total occlusion
by: Barnett, G, et al.
Published: (2014)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
by: Holt-Martyn, J, et al.
Published: (2019)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
by: Flashman, E, et al.
Published: (2010)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
by: Flashman, E, et al.
Published: (2010)

Enhanced Endothelial Tubule Formation in Response to Proly-Hydroxylase Inhibitor FG-2216: A Step Towards Therapeutic Angiogenesis in Chronic Total Occlusions
by: Barnett, G, et al.
Published: (2012)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
by: Chan, M, et al.
Published: (2016)

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase, and is sensitive to off target inhibition by prolyl hydroxylase domain inhibitors that stabilise Hypoxia Inducible Factor
by: Kiriakidis, S, et al.
Published: (2017)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
by: Richardson, NL, et al.
Published: (2021)

Iron homeostasis and its interaction with prolyl hydroxylases.
by: Mole, D
Published: (2010)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
by: Rasheduzzaman Chowdhury, et al.
Published: (2016-08-01)